Erythematous maculopapular rash covering entire body.Physical examination shows an erythematous maculopapular rash covering the infant’s entire body, including the face, trunk, and extremities, but no rash on the palms and soles. Lesions are in various stages of healing, with some appearing vesicular. Mucous membranes are spared. The baby is in no distress and has no other significant findings on examination.The baby undergoes a full sepsis evaluation, including lumbar puncture. Intravenous ampicillin, gentamicin, and acyclovir therapy is started. An umbilical venous line is placed due to difficulty in obtaining percutaneous venous access.The penile foreskin that was removed during circumcision contains a lesion and is sent to pathology in lieu of a skin biopsy.Erythematous maculopapular rash over entire bodyCongenital self-healing Langerhans cell histiocytosisCongenital self-healing Langerhans cell histiocytosis (CSHLCH) is a rare, usually benign, form of Langerhans cell histiocytosis. It was first reported by Hashimoto and Pritzker, who described multiple reddish-brown papulonodules in a newborn girl that showed infiltrating reticulohistiocytes on the skin biopsy and resolved without treatment within a few months. (1) The condition is now alternatively known as Hashimoto-Pritzker disease.The presentation of CSHLCH may mimic other disorders, requiring a thorough evaluation. The other conditions include neonatal hemangiomatosis, (2) congenital infections, pustular melanosis, erythema toxicum, erythropoiesis dermica, and congenital leukemia. (3)In addition to its clinical presentation of a spontaneous eruption of crusted reddish-brown nodules and papules all over the body, the diagnosis is confirmed by pathologic examination of skin containing the papular lesion. Characteristic histologic findings are positive staining for S-100 protein and membranous staining for CD1a antigen in lesional cells. Birbeck granules may also be seen by electron microscopy. Low-density microscopy may show eosinophils or multinucleated giant cells.Kapur and associates(4) published a case series from a 10-year period at Dallas Children’s Medical Center that consisted of 11 cases. All but one of the cases presented at birth; the single other case was diagnosed at 1 month of age. All of the affected infants had only skin involvement at presentation, and all were alive and without evidence of disease at follow-up evaluation.The prognosis for infants who have cutaneous CSHLCH without any other organ involvement is excellent. However, Larralde and associates(5) and others suggest an initial thorough screening evaluation. Such a screening should include a full physical examination; complete blood count; serum chemistry; liver function tests; skull, chest, and long bone radiographs; and abdominal ultrasonography. Bone marrow examination should be performed based on the degree of suspicion of progressive disease. Skin biopsy confirms the diagnosis and is helpful in diagnosing future relapses. Children who have CSHLCH require close follow-up for signs of disease progression, which underscores the importance of making an early diagnosis.JoDee M. Anderson, MD, MEd, Division of Neonatal Medicine, Oregon Health & Science University, Portland, OR.
Read full abstract